Literature DB >> 10063241

Operative results after primary and secondary debulking-operations in advanced ovarian cancer (AOC).

W Lichtenegger1, J Sehouli, E Buchmann, C Karajanev, H Weidemann.   

Abstract

OBJECTIVE: To assess the role of primary and secondary radical surgery in advanced ovarian cancer (AOC).
DESIGN: Retrospective study.
METHODS: One hundred and fifty-one patients with AOC (FIGO III/IV) underwent altogether 191 extended multivisceral operations between 1/1992 and 2/1998. The statistic analysis compared the primary with the secondary operations.
RESULTS: One hundred and seventeen patients had a primary, 63 patients had a secondary and 18 patients a tertiary operation because of relapse of ovarian cancer. Surgical procedures entailed respectively: small-bowel-resection (21%/48%), colon resection (39%/58%), colostomy (9%/11%), ileostomy (2%/4%), ileum-pouch (0%/6), splenectomy (3%/3%), pelvic floor-covering (4%/6%), peritoneal removal (24%/21%), infrared contact coagulation (4%/6%). Seventy-five percent of the patients had no complications: relaparotomy (3%/3%), fistula (3%/6%), short-bowel-syndrome (5%/11%), postoperatively mortality (2%/6%). Postoperative tumor-free were 26%/22%, 57% and 65% had residual disease < or = 2 cm, 16%/13% > 2 cm.
CONCLUSIONS: Radical multivisceral surgery is feasible, safe and efficient in primary as well in secondary situation of advanced ovarian cancer.

Entities:  

Mesh:

Year:  1998        PMID: 10063241     DOI: 10.1111/j.1447-0756.1998.tb00122.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  5 in total

Review 1.  Secondary cytoreduction for patients with recurrent ovarian cancer.

Authors:  Teresa P Díaz-Montes; Robert E Bristow
Journal:  Curr Oncol Rep       Date:  2005-11       Impact factor: 5.075

2.  Altered expression pattern of topoisomerase IIalpha in ovarian tumor epithelial and stromal cells after platinum-based chemotherapy.

Authors:  Radoslav Chekerov; Irina Klaman; Menelaos Zafrakas; Dominique Könsgen; Alexander Mustea; Beate Petschke; Werner Lichtenegger; Jalid Sehouli; Edgar Dahl
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

Review 3.  The role of interval debulking surgery in ovarian cancer.

Authors:  Maria E L van der Burg; Ignace Vergote
Journal:  Curr Oncol Rep       Date:  2003-11       Impact factor: 5.075

Review 4.  Advanced ovarian cancer.

Authors:  M E van der Burg
Journal:  Curr Treat Options Oncol       Date:  2001-04

5.  Clinical management of borderline tumours of the ovary: results of a multicentre survey of 323 clinics in Germany.

Authors:  A Coumbos; J Sehouli; R Chekerov; D Schaedel; G Oskay-Oezcelik; W Lichtenegger; W Kuehn
Journal:  Br J Cancer       Date:  2009-05-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.